EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders

Samiullah Khan, Chi-Wai Do, Emmanuel A Ho iD

Drug Delivery and Translational Research · 2025-06 · 15 (6) · 1828-1876

DOI: 10.1007/s13346-024-01756-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 14.12.2024. Verfasst von Samiullah Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Eye Diseases, Drug Delivery Systems, Drug Carriers, Nanostructures. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 364 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular diseases have a major impact on patient's vision and quality of life, with approximately 2.2 billion people have visual impairment worldwide according to the findings from the World Health Organization (WHO). The eye is a complex organ with unique morphology and physiology consisting of numerous ocular barriers which hinders the entry of exogenous substances and impedes drug absorption. This in turn has a substantial impact on effective drug delivery to treat ocular diseases, especially intraocular disorders which has consistently presented a challenge to eye care professionals. The most common method of delivering medications to the eye is topical instillation of eye drops. Although this approach is a viable option for treating many ocular diseases remains a major challenge for the effective treatment of posterior ocular conditions. Up till now, incessant efforts have been committed to design innovative drug delivery systems with the hopes of potential clinical application. Modern developments in nanocarrier's technology present a potential chance to overcome these obstacles by enabling targeted delivery of the loaded medication to the eyes with improved solubility, delayed release, higher penetration and increased retention. This review covers the anatomy of eye with associated ocular barriers, ocular diseases and administration routes. In addition it primarily focuses on the latest progress and contemporary applications of ophthalmic formulations providing specific insight on nanostructured drug delivery carriers reported over the past 5 years highlighting their values in achieving efficient ocular drug delivery to both anterior and posterior segments. Most importantly, we outlined in this review the macro and nanotechnology based ophthalmic drug formulations that are being patented or marketed so far for treating ocular diseases. Finally, based on current trends and therapeutic concepts, we highlighted the challenges faced by novel ocular drug delivery systems and provided prospective future developments for further research in these directions. We hope that this review will serve as a source of motivation and ideas for formulation scientists in improving the design of innovative ophthalmic formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye DiseasesDrug Delivery SystemsDrug CarriersNanostructuresOphthalmic SolutionsHumansAnimalsAdministration, OphthalmicPosterior Eye Segment

Stichwörter der Autor:innen

Drug carriersMarketed productsOcular diseasesOphthalmic barriersOphthalmic routesPatented products

Substanzen

Drug CarriersOphthalmic Solutions

Autor:innen und Institutionen

  • Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong, Hong Kong.
  • Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong, Hong Kong. chi-wai.do@polyu.edu.hk.
  • School of Optometry, The Hong Kong Polytechnic University, Hung Hom, Hong Kong. chi-wai.do@polyu.edu.hk.
  • Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong, Hong Kong. Emmanuel.ho@uwaterloo.ca.
  • School of Pharmacy, University of Waterloo, Waterloo, Canada. Emmanuel.ho@uwaterloo.ca.
  • Waterloo Institute for Nanotechnology, Waterloo, Canada. Emmanuel.ho@uwaterloo.ca.

ORCID-Profile: Emmanuel A Ho

Zitieren

APA

Khan, S., Do, C. W., & Ho, E. A. (2025). Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders. Drug Delivery and Translational Research, 15(6), 1828-1876. https://doi.org/10.1007/s13346-024-01756-x

Vancouver

Khan S, Do CW, Ho EA. Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders. Drug Delivery and Translational Research. 2025;15(6):1828-1876. doi:10.1007/s13346-024-01756-x

BibTeX
@article{Khan2025,
  author = {Khan, Samiullah and Do, Chi-Wai and Ho, Emmanuel A},
  title = {Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {1828--1876},
  doi = {10.1007/s13346-024-01756-x}
}
Kostenlos starten →